Symbiotec Pharmalab Limited IPO
Pharmaceuticals · DRHP 19 Dec 2025 · RHP 18 Aug 2026 · listed 1 Sept 2026
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹988.00
- band ₹938.00 to ₹988.00
- Issue size
- ₹1,757.0 cr
- fresh ₹150 cr · OFS ₹1,607 cr
- Lot
- 15 shares
- ₹14,820 at the top of the band
- Subscription window
- 24 Aug to 27 Aug
- 2026
- Listing
- 1 Sept 2026
- NSE
- Subscribed
- 58.3x
- retail 8.3x
About the Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited raised ₹1,757 crore through a mainboard IPO on NSE and BSE: a fresh issue of ₹150 crore and an offer for sale of ₹1,607 crore. The fresh issue goes to the company; the offer for sale goes to the shareholders selling.
Bidding ran Mon 24 Aug to Thu 27 Aug, at an issue price of ₹988 a share, in lots of 15 shares. The shares listed on 1 Sept 2026.
The book-running lead managers are JM Financial Limited, Avendus Capital Private Limited and Motilal Oswal Investment Advisors Limited. The registrar, which handles allotment, is MUFG Intime India Private Limited.
The issue was subscribed 58.32 times overall, with the retail portion at 8.27 times, as the exchange's bid book showed.
The draft offer document was filed on 19 Dec 2025, and the red herring prospectus on 18 Aug 2026.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Symbiotec Pharmalab IPO: questions answered
When was the Symbiotec Pharmalab IPO open, and what were the price band and lot size?
Bidding ran Mon 24 Aug to Thu 27 Aug. The issue price is ₹988 a share. One lot is 15 shares, ₹14,820 at the upper end of the band.
When did the Symbiotec Pharmalab IPO list?
The shares listed on 1 Sept 2026 on NSE and BSE.
How do I check the Symbiotec Pharmalab IPO allotment status?
Allotment is finalised by the registrar, MUFG Intime India Private Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Symbiotec Pharmalab IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Symbiotec Pharmalab IPO?
The book-running lead managers are JM Financial Limited, Avendus Capital Private Limited and Motilal Oswal Investment Advisors Limited. The registrar, which handles applications and allotment, is MUFG Intime India Private Limited.
How many times was the Symbiotec Pharmalab IPO subscribed?
58.32 times overall, as the exchange's bid book last showed: qualified institutions 142.28 times, non-institutional investors 42.25 times and retail 8.27 times.
Is the Symbiotec Pharmalab IPO a fresh issue or an offer for sale?
A fresh issue of ₹150 crore, which goes to the company, and an offer for sale of ₹1,607 crore, which goes to the shareholders selling (91% of the issue).
What is the Symbiotec Pharmalab IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Symbiotec Pharmalab IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.